Benitec Biopharma (BNTC) Change in Accured Expenses (2019 - 2025)
Benitec Biopharma (BNTC) reported Change in Accured Expenses of $19000.0 for Q4 2025, up 120.43% on a YoY basis from $8619.5 in Q4 2024, and down 48.65% sequentially from $37000.0 in Q3 2025.
Benitec Biopharma (BNTC) Change in Accured Expenses (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Change in Accured Expenses data on file, last reported at $19000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Accured Expenses rose 120.43% year-over-year to $19000.0; the trailing twelve-month figure through Dec 2025 stood at $52000.0 (up 161.9% YoY), and the FY2025 full-year result was -$81000.0, down 307.69% from the prior year.
- Change in Accured Expenses declined to $19000.0 in Q4 2025, from $37000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $159000.0 in Q1 2025 to a low of -$163000.0 in Q2 2025.
- A 5-year average of $13150.0 and a median of $17500.0 in 2024 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 7850.0% in 2025, while the deepest fall reached 1711.11% in 2025.
- Tracing BNTC's Change in Accured Expenses over 5 years: stood at $3000.0 in 2021, then surged by 100.0% to $6000.0 in 2022, then jumped by 733.33% to $50000.0 in 2023, then tumbled by 286.0% to -$93000.0 in 2024, then soared by 120.43% to $19000.0 in 2025.
- Business Quant data shows BNTC's Change in Accured Expenses at $19000.0 in Q4 2025, $37000.0 in Q3 2025, and -$163000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | 19,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19,000.00 |
| Dec 31, 2025 | 19,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Jun 30, 2025 | -163,000.00 |
| Jun 30, 2025 | -163,000.00 |
| Mar 31, 2025 | 159,000.00 |
| Mar 31, 2025 | 159,000.00 |
| Dec 31, 2024 | -93,000.00 |
| Dec 31, 2024 | -93,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | -9,000.00 |
| Jun 30, 2024 | -9,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Sep 30, 2023 | -4,000.00 |